PDL BioPharma
在场
PDL BioPharma 是一家在股票代码 PDLI (US) 下上市的公司。
高管
查看带有其 4 名主要高管的组织结构图
PDL BioPharma 搜索最多的简介
- Christopher Stone, Chief Executive Officer, General Counsel and Se...
- Elizabeth O'Farrell, Chairman of the Board
- Dominique Monnet, Director
创建提醒
跟踪 PDL BioPharma 的高管变动
药店
PDL BioPharma 拥有 1,840 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
药店 行业的其他推荐联系人
消息
PDL BioPharma 的最新新闻稿
- Press Releases | PDL BioPharma, Inc.
- Press Releases | PDL BioPharma, Inc.
- Press Releases | PDL BioPharma, Inc.
- Press Releases | PDL BioPharma, Inc.
- Press Releases | PDL BioPharma, Inc.
- Sign Up | LinkedIn
- RSS News Feeds | PDL BioPharma, Inc.
- PDL BioPharma Completes Spin-Off of LENSAR | PDL BioPharma, Inc.
- PDL BioPharma to Complete Spin-Off of LENSAR, Inc. on October 1, 2020 | PDL BioPharma, Inc.
- PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital | PDL BioPharma, Inc.
- View more press releases Close
通过电子邮件
